Lisata Therapeutics, Inc. Stock Analysis & AI Score
Lisata Therapeutics, Inc. (LSTA) has an ST Score of 30.0 (C-), driven by its Growth (B) and held back by its Profitability (F). Analysts rate it Hold.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Lisata Therapeutics, Inc. (LSTA) has an ST Score of 30.0 (C-), driven by its Growth (B) and held back by its Profitability (F). Analysts rate it Hold.
- Strongest
- GrowthB
- Weakest
- ProfitabilityF
All factor grades
- GrowthB
- Financial StrengthB-
- ValuationC
- MomentumD
- ProfitabilityF
- Piotroski1/9
Contact
LSTA stock: frequently asked questions
What is LSTA's ST Score?
Lisata Therapeutics, Inc. (LSTA) has an ST Score of 30.0 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LSTA a buy, hold, or sell?
Analysts rate LSTA a Hold. Our ST Score grades it C- (30.0/100). The ST Score is a data-driven signal, not a recommendation.
What are LSTA's factor grades?
Valuation C, Profitability F, Financial Strength B-, Momentum D, Growth B.
What is LSTA's valuation grade?
Lisata Therapeutics, Inc. (LSTA) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LSTA's growth grade?
Lisata Therapeutics, Inc. (LSTA) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LSTA's profitability grade?
Lisata Therapeutics, Inc. (LSTA) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LSTA's financial strength grade?
Lisata Therapeutics, Inc. (LSTA) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is LSTA's Piotroski score?
Lisata Therapeutics, Inc. (LSTA) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.